The question arose because the AstraZeneca vaccine has not yet been approved for use in the United States by the Food and Drug Administration (FDA).
Thierry Breton, EU Internal Market Commissioner, said he spoke to White House Covid Response Coordinator Jeff Zients about the vaccine and was told it would belong to the Centers for Disease Control and Prevention (CDC) to decide.
Mr Breton, who is currently visiting the United States, said Mr Zients appeared “positive and optimistic”.
Today, the United States announces the lifting of the travel ban for fully vaccinated Europeans.
Intense negotiations have paid off – and the EU vaccine # Intervention force will continue to work with the Biden administration on other important topics such as supply chains. pic.twitter.com/lemqIaGnRZ
– Thierry Breton (@ThierryBreton) September 20, 2021
The US is set to lift the travel ban on fully vaccinated travelers from the EU, UK and several other countries “in early November,” more than a year and a half after the introduction of the ‘prohibition.
A spokesperson for the CDC said Monday, September 20, that the organization considers a person to be fully vaccinated with any vaccine authorized by the FDA and any vaccine authorized by the World Health Organization (WHO).
The AstraZeneca vaccine has been approved for emergency use by the WHO, but this is not official confirmation that the United States will accept travelers vaccinated with this vaccine.
About 10 million doses of the AstraZeneca vaccine have been administered in France. The vast majority of French people have received the Pfizer-BioNTech vaccine, which is approved by the FDA.
Regional news outlets in the UK, where the AstraZeneca vaccine has been most widely used, report that a spokesperson for the Prime Minister said he was “confident” that the AstraZeneca vaccine would be recognized by US border officials .
US to allow vaccinated visitors from EU to come from November